Literature DB >> 18548155

Solvent effects on IR and VCD spectra of natural products: an experimental and theoretical VCD study of pulegone.

Elke Debie1, Patrick Bultinck, Wouter Herrebout, Benjamin van der Veken.   

Abstract

The VCD spectra of pulegone, dissolved in CDCl3, CD2Cl2 and CS2 have been recorded in the frequency range from 1000 to 3000 cm(-1). The assignment of the absolute configuration was performed by comparing the experimental data with theoretical spectra computed at the B3LYP/6-311+G(d,p) level. Analysis of the agreement in several spectral regions revealed significant shortcomings when comparing with vacuum calculations. It is shown that the agreement improves when the solvent effects are taken into account by a continuum model. For the measurements in CDCl3 and CD2Cl2 further improvement was found when considering explicitly 1 : 1 complexes between a pulegone and a CDCl3 or CD2Cl2 solvent molecule in vacuo, while the best agreement was obtained when embedding these in a continuum model. The presence of the chiral solute was found to induce a VCD active C-D stretch band which could be modeled also at ab initio level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18548155     DOI: 10.1039/b801313f

Source DB:  PubMed          Journal:  Phys Chem Chem Phys        ISSN: 1463-9076            Impact factor:   3.676


  2 in total

1.  Importance of solvation in understanding the chiroptical spectra of natural products in solution phase: garcinia acid dimethyl ester.

Authors:  Prasad L Polavarapu; Giovanni Scalmani; Edward K Hawkins; Carmelo Rizzo; Neha Jeirath; Ibrahim Ibnusaud; Deenamma Habel; Divya Sadasivan Nair; Simimole Haleema
Journal:  J Nat Prod       Date:  2010-11-29       Impact factor: 4.050

Review 2.  The Clusters-in-a-Liquid Approach for Solvation: New Insights from the Conformer Specific Gas Phase Spectroscopy and Vibrational Optical Activity Spectroscopy.

Authors:  Angelo S Perera; Javix Thomas; Mohammad R Poopari; Yunjie Xu
Journal:  Front Chem       Date:  2016-02-25       Impact factor: 5.221

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.